Document:

PROMISSORY NOTE IN THE AMOUNT OF 1,000,000

 Exhibit 10.3 
 PROMISSORY NOTE 
  

					
	$1,000,000.00	  	Dripping Springs,	  	Texas March 19, 2012

 FOR VALUE RECEIVED, HEALTHMONT OF MISSOURI, LLC, a Georgia limited liability company
(“Maker”), promises to pay to the order of PIONEER BANK, S.S.B. (“Payee”), at P. O. Box 4, Dripping Springs, Texas 78620, or such other address as Payee may from time to designate, the sum of ONE
MILLION AND NO/100 DOLLARS ($1,000,000.00) in legal and lawful money of the United States of America, together with interest thereon from date hereof at the rates describe below. Interest shall be computed on the basis of a 360 day year.

 The interest rate due under this promissory note (the “Note”) commencing on the date
hereof continuing until this Note is paid in full, shall be the greater of (i) five percent (5%) per annum or (ii) Base Rate PLUS 2.0%, but the interest rate shall in no event ever exceed the Maximum Lawful Rate. The interest rate
shall be adjusted quarter-annually, without notice to Maker, on the 19th day of each June, September, December and March of each year with changes in the Base Rate. 
 The term “Base Rate”, means the interest rate most recently established and published by the Wall Street Journal as its prime interest rate. If the Wall Street Journal prime interest rate ceases
to be available, Payee will choose a new interest rate index based upon comparable information. The Base Rate will automatically fluctuate upward and downward, without special notice to Maker or any other person. THE BASE RATE MAY NOT BE THE BEST
OR LOWEST RATE CHARGED BY PAYEE OR A FAVORED RATE OF INTEREST, AND ANY REPRESENTATION OR WARRANTY IN THAT REGARD IS EXPRESSLY DISCLAIMED. 
 The term “Maximum Lawful Rate”, means the lesser of (i) the highest rate permitted by applicable Texas or United States law, or (ii) an annual rate equal to the weekly ceiling
determined in accordance with the computation specified in the Texas Finance Code, as amended, as such weekly ceiling is in effect from time to time, but in no event greater than eighteen (18%) percent annually. Unless precluded by law, changes
in the Maximum Lawful Rate created by statute or governmental action during the term of this Note shall be immediately applicable to this Note on the effective date of such changes. 

This Note is a “draw” note written in the full principal amount that may be drawn by Maker in separate interim draws for the
construction and completion of certain improvements on the real property hereinafter described. Interest shall accrue only from the date funds are advanced, and the liability of Maker is limited to the unpaid principal actually drawn plus unpaid
interest, plus such other expenses as may be specifically provided for in this Note or in the related Collateral Agreements (hereinafter defined). This Note is one of two Notes of Maker aggregating an amount not to exceed $1,000,000.00 arising out
of a Loan Agreement dated as of March 19, 2012, as the same may be from time to time amended, entered into by Maker with Payee (the “Loan Agreement”). 
 This Note is due and payable as follows, to-wit: 

  
 Page 1 of a 6
Page 
 $1,000,000.00 Promissory Note 

 Interest only shall be due and payable monthly as it accrues, commencing
on April 19, 2012 and continuing regularly and monthly thereafter until March 19, 2013; thereafter, principal and interest thereon shall be amortized over a period of 24 years from March 19, 2013 through March 19, 2037 (the
“Amortization Period”) and regular monthly payments of principal and interest thereon shall be recalculated each June 19, September 19, December 19 and March 19 of each year to be equal to the then principal
balance of the Note at the then annual interest rate described above and then amortized over then remaining Amortization Period, with monthly payments commencing on April 19, 2013 and continuing regularly and monthly thereafter on or before the
19th day of each month thereafter until March 19,
2037, when the entire principal amount and accrued interest thereon shall be paid in full. 
 Payment of this Note is secured
by, and the holder of this Note is entitled to the benefits of, all deeds of trust, mortgages, security agreements, assignments, lien instruments, guaranties, endorsements, or other agreements (“the Collateral Agreements”) executed or
created by any person or entity (including but not limited to Maker) to secure payment of this Note. Without limiting the foregoing, the Collateral Agreements include: 
 A Deed of Trust, Security Agreement and Fixture Filing of even date herewith, conveying the real property more fully described on Exhibit “A” attached hereto and incorporated herein for all
purposes, in trust, to Thomas Riley, as trustee for Payee. 
 Upon the occurrence of an Event of Default (as defined in the Loan
Agreement), the holder hereof may, at its option, in so long as such Event of Default shall be continuing, declare the entirety of this Note, principal and interest, immediately due and payable, and pursue any and all other remedies available to it
at law or in equity, but failure to do so at any time shall not constitute a waiver of such holder’s right to do so at any other time. Failure to exercise this option upon any default shall not constitute a waiver of the right to exercise it in
the event of any subsequent defaults. 
 Upon the occurrence and during the continuance of any Event of Default and after any
applicable notice and grace period, at the option of Payee, the unpaid balance of this Note shall be matured, and if Maker defaults in the prompt payment of this Note when due or declared due, and this Note is placed in the hands of an attorney for
collection, or suit is brought on this Note, or this Note is collected through probate, bankruptcy or other judicial proceedings, then Maker, jointly and severally if more than one, agrees and promises to pay all reasonable attorney’s fees,
court costs and collection expenses incurred by Payee. 
 If at any time and from time to time Payee is prevented from
collecting the rate of interest and the fees specified in this Note by applicable law or governmental regulation, Payee shall nevertheless be entitled to recoup the difference between the amount collected and the amount it would have otherwise been
able to collect (the “Recoupment Amount”) during such period, only, when the recoupment will not violate applicable law or regulation (the “Recoupment Period”). During each Recoupment Period, Maker shall continue to pay the
Maximum Lawful Rate until there has been paid under this Note, in addition to the interest at the applicable rate specified herein during such Recoupment Period, an amount equal to the Recoupment Amount. Interest collected

  
 Page 2 of a 6
Page 
 $1,000,000.00 Promissory Note 

 
by Payee during each Recoupment Period shall first be applied to payment of current interest due at the applicable rate specified in this Note and any remaining interest collected shall be
applied to the Recoupment Amount. When Payee has recouped all of the Recoupment Amount, the interest rate payable by Maker shall revert to the applicable rate specified in this Note. In no event, however, shall the interest rate charged hereunder
ever exceed the Maximum Lawful Rate and in the event of any prepayment of this Note, only that portion of the Recoupment Amount which has been earned through the date of prepayment shall be payable. 

Upon the occurrence of an Event of Default, and after any applicable notice and grace period, this Note and all
obligations contained in any Collateral Agreements shall become immediately due at the election of Payee. Maker and each surety, endorser, guarantor and any other party liable for payment of this Note, in whole or in part, hereby severally:
(i) waive demand, presentment for payment, notice of nonpayment, protest, notice of protest, notice of intent to accelerate, notice of acceleration, dishonor, and all other waivable notices, and diligence in collecting this Note or enforcing
any of the Collateral Agreements; (ii) agree to any substitution, subordination, exchange or release of any party primarily or secondarily liable for payment of this Note; (iii) agree that Payee shall not be required first to institute
suit or exhaust Payee’s remedies against Maker or others liable for payment of this Note or performance under any Collateral Agreement; and (iv) consent to any extension or postponement of time of payment of this Note and to any other
indulgence with respect hereto without notice to any of them, Payee’s failure to exercise Payee’s option to accelerate upon any default shall not constitute a waiver of the right to exercise it in the event of any subsequent default.

 Limitation of Interest: Maker confirms that Maker is not aware of any violation of applicable usury laws related to this Note
or any Collateral Agreement. The parties intend to conform strictly to the applicable usury laws and, to induce Payee to make a loan to Maker, Maker agrees that: 
 All existing or future agreements and transactions between Maker and the Payee are expressly limited so that under no circumstance shall the amount of Interest, as defined below, exceed the Maximum Lawful
Rate. 
 If, under any possible construction of this Note or any Collateral Agreement, Excess Interest, as defined below, would
otherwise be payable, any Excess Interest shall be automatically, as of the date of charging or payment, applied to a reduction of the principal balance of this Note and not to the payment of interest, or if the Excess Interest exceeds the unpaid
principal balance of this Note it shall be refunded to Maker, and this Note and/or the Collateral Agreement shall be automatically reformed to reduce the Interest payable to the maximum legal rate without the necessity of execution of an amending
document. 
 If Maker discovers that this Note or any of the Collateral Agreements may violate any applicable usury law, Maker
shall notify Payee of the alleged violation and shall give Payee sixty days to cure the violation. During the sixty day notice and cure period, Maker shall not prosecute any claim or defense based upon a violation of applicable usury laws.

 To the extent not prohibited by law, all Interest shall be amortized, prorated and spread, in equal parts, over the full
stated term of this Note so that the actual rate of Interest is uniform through the term of this Note. 

  
 Page 3 of a 6
Page 
 $1,000,000.00 Promissory Note 

 “Excess Interest” shall mean all interest or fees charged, collected, or received
in excess of the Maximum Lawful Rate of interest, including, but not limited to, those arising due to acceleration of maturity, late fees, prepayment, or demand for prepayment. 

For purposes of this Limitation Of Interest section, and only this section, the term “Interest” shall be all inclusive and
shall mean the amount of interest contracted for, charged, or received by Payee from Maker, or any third party, for the use, forbearance, or detention of the principal of this Note. 

If any installment becomes overdue for more than five (5) days, at Payee’s option, five percent (5%) of the overdue
installment amount will be charged in order to defray the expense of handling the delinquent payment. 
 In the event any
portion of this Note is paid prior to the date such amount is due, whether such payment is made voluntarily or involuntarily (including as a result of an acceleration under the Collateral Agreements), Maker will pay to Payee, within (15) days
of the Bank’s written demand, a prepayment fee equal to 5.0% of the prepaid amount received during the period commencing on the date hereof and continuing until the fifth annual anniversary date hereof. All prepayments shall be applied first to
accrued but unpaid interest, and the balance applied to installments due hereon in inverse order of maturity. Maker acknowledges and agrees that it is extremely difficult and impracticable to ascertain the amount of losses that would be incurred by
Payee if Maker prepays this Note as described above. Maker therefore agrees that the foregoing prepayment fees are a reasonable and bargained for understanding between the parties. 

This Note shall be governed by and construed in accordance with the laws of the State of Texas. 

Facsimile—An (i) electronic transmission or other facsimile of this Note and (ii) electronically generated signature on
this Note shall be deemed an original for purposes of admission into evidence of this Note and signer’s execution. 

THIS NOTE AND THE INSTRUMENTS BEING EXECUTED ALONG WITH IT REPRESENT THE FINAL AGREEMENT BETWEEN THE PARTIES AND MAY NOT BE
CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENT OF THE PARTIES. 
 THERE ARE NO UNWRITTEN
ORAL AGREEMENTS BETWEEN THE PARTIES. 
 USA Patriot Act Notification. The following notification is provided to Maker pursuant
to Section 326 of the USA Patriot Act of 2001, 31 U.S.C. Section 5318: 
 Payee hereby notifies Maker that pursuant
to the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Act”), it is required to obtain, verify and record information that identifies Maker, which information includes the
name and address of Maker and other information that will allow Payee to identify Maker in accordance with the Act. 

  
 Page 4 of a 6
Page 
 $1,000,000.00 Promissory Note 

 MAKER: 
 HealthMont of Missouri, LLC 
 A Georgia limited liability company 

By its Sole Member: 
 HealthMont,
LLC 
 A Georgia limited liability company 
 By its Sole Member: 
 SunLink Health Systems, Inc. 

An Ohio corporation 
 By:                                 
                                    

Name:                     
                                    

Title:                     
                                         
   

  
 Page 5 of a 6
Page 
 $1,000,000.00 Promissory Note 

 EXHIBIT “A” 
 LEGAL DESCRIPTION: 
 Part of Section 18, Township 47 North, Range 9 West, Callaway County,
Missouri, described as follows: Commencing at an Aluminum State Monument at the Southeast corner of said Section 18’; thence North 81 degrees 44’ 27” West, 1041.05 feet to a 1/2 inch iron pin at the Southwest corner of Lot 1, of
the Corrected Plat of Westminster College Subdivision, Recorded in Plat Book 8, Page 12, said point being the True Point of Beginning; thence North 89 degrees 18’ 24” East along the North right of way line of South Hospital Drive, 165.00
feet to a 1/2 inch iron pin at a point of curve; thence continuing along said North right of way line on a curve to the left having a central angle of 25 degrees 05’ 08”, a radius of 795.00 feet, an arc distance of 348.07 feet, and a chord
bearing and distance of North 76 degrees 45’ 50” East, 345.30 feet to a point of compound curve; thence continuing along said right of way line in a Northeasterly to Northwesterly direction, on a curve to the left having a central angle of
88 degrees 50’ 00”, a radius of 625.00 feet, an arc distance of 969.02 feet, and a chord bearing and distance of North 19 degrees 48’ 19” East, 874.84 feet to a point of reverse curve; thence continue on the Westerly right of way
line of said South Hospital Drive in a Northwesterly direction on a curve to the right having a central angle of 16 degrees 15’ 00”, a radius of 1065.00 feet, an arc distance of 302.05 feet, and a chord bearing and distance of North 16
degrees 29’ 13” West, 301.04 feet to a concrete monument on the South right of way line of Missouri State Route “F”, thence South 81 degrees 38’ 16” West along said right of way line, 135.00 feet to a 1/2 inch iron pin
at a point of curve; thence continue along said right of way line on a curve to the right having a central angle of 17 degrees 07’ 09”, a radius of 1562.69 feet, an arc distance of 466.91 feet, and a chord bearing and distance of North 81
degrees 18’ 24” West, 465.17 feet to a 1/2 inch iron pin; thence leaving said right of way line South 20 degrees 28’ 53” West, 152.75 feet to a 1/2 inch iron pin; thence North 89 degrees 58’ 07” West, 57.31 feet
to a 1/2 inch iron pin at the Northwest corner of said Lot 1; thence South 0 degrees 15’ 35” West, along the West line of said Lot 1, 1076.28 feet to the True Point of Beginning, 
 EXCEPT THEREFROM a tract of land being a part of Lot 1 of the corrected plat of Westminster College Subdivision #1, a subdivision filed for public record in Plat Book 8, Page 12, of Callaway County Land
Records, located in Section 18, Township 47 North, Range 9 West, Callaway County, Missouri, described as follows: 
 Commencing at a point
on the northern right of way line of South Hospital Drive, 50 feet wide, said point being on the South boundary line of said Lot 1, said point bears North 89 degrees 18 minutes 24 seconds East, 39.17 feet from the Southwest corner of said Lot 1;
thence leaving said right of way line along the projection of the southeast wall of the existing Hospital North 49 degrees 45 minutes 02 seconds east, 582.58 feet to the corner of the existing wall; thence South 12 degrees 32 minutes 32 seconds
East, 32.76 feet to the True Point of Beginning; thence South 40 degrees 14 minutes 58 seconds East, 32.87 feet to a point; thence South 49 degrees 45 minutes 02 seconds West, 39.33 feet to a point; thence North 40 degrees 14 minutes 58 seconds
West, 32.87 feet to a point; thence North 49 degrees 45 minutes 02 seconds East, 39.33 feet to the True Point of Beginning. 

  
 Page 6 of a 6
Page 
 $1,000,000.00 Promissory NoteForm of Warrant issued in connection with the Warrant Purchase Agreement

 Exhibit 4.1 
 Form of Warrant 
 THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER APPLICABLE SECURITIES LAWS AND HAVE BEEN ISSUED IN RELIANCE UPON AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH OTHER
SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE REOFFERED, SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED, HYPOTHECATED OR OTHERWISE DISPOSED OF, EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OR PURSUANT TO A TRANSACTION WHICH IS EXEMPT FROM, OR NOT SUBJECT TO, SUCH REGISTRATION, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM, OR NOT SUBJECT TO, SUCH
REGISTRATION, UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND SUCH OTHER APPLICABLE LAWS. 

 

			
	WARRANT NO.                     	 	NUMBER OF SHARES:                     
	DATE OF ISSUANCE:                     , 2012	 	(subject to adjustment)

 WARRANT TO PURCHASE SHARES 
 OF COMMON STOCK OF 
 CORCEPT THERAPEUTICS INCORPORATED 

This Warrant is issued to
                    , or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain
Warrant Purchase Agreement, dated as of March 25, 2012, between Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase
Agreement”) and is subject to the terms and conditions of the Purchase Agreement. 
 1. EXERCISE OF WARRANT.

 (a) Method of Exercise. Subject to the terms and conditions herein set forth, upon surrender of this Warrant at the
principal office of the Company and upon payment of the Warrant Price (as defined below) by wire transfer to the Company or cashier’s check drawn on a United States bank made payable to the order of the Company, the Purchaser is entitled to
purchase from the Company, at any time after the date hereof and on or before 5:00 p.m. New York City time on March 29, 2015 (the “Expiration Date”), up to
                    shares (as adjusted from time to time pursuant to the provisions of this Warrant) of Common Stock (as defined below) of the
Company (the “Warrant Stock”), at a purchase price of $4.05 per share (the “Warrant Price”), subject to adjustment as set forth herein. 

 2. CERTAIN ADJUSTMENTS. 

(a) Mergers or Consolidations. If at any time after the date hereof there shall be a capital reorganization (other than a
combination or subdivision of Warrant Stock otherwise provided for herein) (a “Reorganization”), or a merger or consolidation of the Company with another corporation (other than a merger with another corporation in which the Company
is a continuing corporation and which does not result in any reclassification or change of outstanding securities issuable upon exercise of this Warrant or a merger effected exclusively for the purpose of changing the domicile of the Company) (a
“Merger”), then, as a part of such Reorganization or Merger, lawful provision shall be made so that the Purchaser shall thereafter be entitled to receive upon exercise of this Warrant, during the period specified in this Warrant and
upon payment of the Warrant Price, the number of shares of stock or other securities or property of the Company or the successor corporation resulting from such Reorganization or Merger, to which a holder of the Common Stock deliverable upon
exercise of this Warrant would have been entitled under the provisions of the agreement in such Reorganization or Merger if this Warrant had been exercised immediately before that Reorganization or Merger. In any such case, appropriate adjustment
(as determined in good faith by the Company’s Board of Directors) shall be made in the application of the provisions of this Warrant with respect to the rights and interests of the Purchaser after the Reorganization or Merger to the end that
the provisions of this Warrant (including adjustment of the Warrant Price then in effect and the number of shares of Warrant Stock) shall be applicable after that event, as near as reasonably may be, in relation to any shares or other property
deliverable after that event upon exercise of this Warrant. The above provisions of this paragraph shall similarly apply to successive reorganizations, reclassifications, exchanges, liquidations, recapitalizations, changes, consolidations, mergers,
sales, transfers or other dispositions, if any. 
 (b) Splits and Subdivisions; Dividends. In the event the Company
should at any time, or from time to time, fix a record date for the effectuation of a split or subdivision of the outstanding shares of Common Stock or the determination of the holders of Common Stock entitled to receive a dividend or other
distribution payable in additional shares of Common Stock or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly, additional shares of Common Stock (hereinafter referred to as the
“Common Stock Equivalents”) without payment of any consideration by such holder for the additional shares of Common Stock or Common Stock Equivalents (including the additional shares of Common Stock issuable upon conversion or
exercise thereof), then, as of such record date (or the date of such distribution, split or subdivision if no record date is fixed), the per share Warrant Price shall be appropriately decreased and the number of shares of Warrant Stock shall be
appropriately increased in proportion to such increase (or potential increase) of outstanding shares. 
 (c) Combination of
Shares. If the number of shares of Common Stock outstanding at any time after the date hereof is decreased by a combination of the outstanding shares of Common Stock, the per share Warrant Price shall be appropriately increased and the number of
shares of Warrant Stock shall be appropriately decreased in proportion to such decrease in outstanding shares. 
 (d)
Adjustments for Other Distributions. In the event the Company shall declare a distribution payable in securities of other persons, evidences of indebtedness issued by the 

  
 2 

 
Company or other persons, assets (excluding cash dividends paid out of net profits) or options or rights not referred to in Section 2(b), then, in each such case for the purpose of this
Section 2(d), upon exercise of this Warrant the holder hereof shall be entitled to a proportionate share of any such distribution as though such holder was the holder of the number of shares of Common Stock into which this Warrant may be
exercised as of the record date fixed for the determination of the holders of Common Stock entitled to receive such distribution. 
 3. NO FRACTIONAL SHARES. No fractional shares of Warrant Stock will be issued in connection with any exercise of this Warrant. In lieu of any fractional shares which would otherwise be issuable, the
Company shall pay cash equal to the product of such fraction multiplied by the Fair Market Value of one share of Warrant Stock. 

4. NO STOCKHOLDER RIGHTS. Until the exercise of this Warrant or any portion of this Warrant, the Purchaser shall not have nor exercise
any rights by virtue hereof as a stockholder of the Company (including without limitation the right to notification of stockholder meetings or the right to receive any notice or other communication concerning the business and affairs of the
Company). 
 5. RESERVATION OF STOCK. The Company covenants that during the period this Warrant is exercisable, the Company will
reserve from its authorized and unissued Common Stock a sufficient number of shares of Common Stock (or other securities, if applicable) to provide for the issuance of Warrant Stock (or other securities) upon the exercise of this Warrant. The
Company agrees that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of executing stock certificates to execute and issue the necessary certificates for the Warrant Stock upon the exercise of
this Warrant. 
 6. MECHANICS OF EXERCISE. This Warrant may be exercised by the holder hereof, in whole or in part, by the
surrender of this Warrant and the Notice of Exercise attached hereto as Exhibit A duly completed and executed on behalf of the holder hereof, at the principal office of the Company together with payment in full of the Warrant Price then in
effect with respect to the number of shares of Warrant Stock as to which the Warrant is being exercised. This Warrant shall be deemed to have been exercised immediately prior to the close of business on the date of its surrender for exercise as
provided above, and the person entitled to receive the Warrant Stock issuable upon such exercise shall be treated for all purposes as the holder of such shares of record as of the close of business on such date. As promptly as practicable on or
after such date, the Company at its expense shall cause to be issued and delivered to the person or persons entitled to receive the same a certificate or certificates for the number of full shares of Warrant Stock issuable upon such exercise,
together with cash in lieu of any fraction of a share as provided above. The shares of Warrant Stock issuable upon exercise hereof shall, upon their issuance, be validly issued, fully paid and nonassessable, and free from all preemptive rights,
taxes, liens and charges with respect to the issue thereof. In the event that this Warrant is exercised in part, the Company at its expense will execute and deliver a new Warrant of like tenor exercisable for the number of shares for which this
Warrant may then be exercised. 
 7. CERTIFICATE OF ADJUSTMENT. Whenever the Warrant Price or number or type of securities
issuable upon exercise of this Warrant is adjusted, as herein provided, the Company shall, at its expense, promptly deliver to the Purchaser a certificate of an officer of the Company setting forth the nature of such adjustment and showing in detail
the facts upon which such adjustment is based. 

  
 3 

 8. REPRESENTATIONS OF PURCHASER. As of the date hereof, the Purchaser hereby confirms the
representations and warranties made by the Purchaser in Section 5 of the Purchase Agreement. 
 9. COMPLIANCE WITH
SECURITIES LAWS. 
 (a) The Purchaser understands that this Warrant and the Warrant Stock are characterized as “restricted
securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations this Warrant and the Warrant Stock may be
resold without registration under the Securities Act only in certain limited circumstances. In this connection, the Purchaser represents that it is familiar with Rule 144 under the Securities Act of 1933, as amended (the “Securities
Act”), as presently in effect, and understands the resale limitations imposed thereby and by the Securities Act. 

(b) Prior and as a condition to any exercise of this Warrant or the sale or transfer of the Warrant Stock issuable upon exercise of this
Warrant, the Purchaser shall furnish to the Company such certificates, representations, agreements and other information, including an opinion of counsel, as the Company or the Company’s transfer agent reasonably may require to confirm that
such exercise, sale or transfer is being made pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act unless such Warrant Stock is being sold or transferred pursuant to an effective
registration statement. 
 (c) The Purchaser acknowledges that the Company may place a restrictive legend on the Warrant Stock
issuable upon exercise of this Warrant in order to comply with securities laws unless such shares of Warrant Stock are otherwise freely tradable under Rule 144 of the Securities Act. 

10. NOTICES OF RECORD DATE. In the event of: 
 (a) any taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend
payable out of earned surplus of the Company) or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of stock of any class or any other securities or property, or to receive any other right; or 

(b) any Reorganization or Merger; or 
 (c) any voluntary or involuntary dissolution, liquidation or winding-up of the Company, 
 then and
in each such event the Company will mail or cause to be delivered to the Purchaser (or a permitted transferee in compliance with Section 9 above) a notice specifying (i) the date on which any such record is to be taken for the purpose of
such dividend, distribution or right, and stating the amount and character of such dividend, distribution or right, and (ii) the date on which 

  
 4 

 
any such Reorganization, Merger, dissolution, liquidation or winding-up is to take place, and the time, if any, as of which the holders of record of Common Stock (or other securities) shall be
entitled to exchange their shares of Common Stock (or other securities) for securities or other property deliverable upon such Reorganization, Merger, dissolution, liquidation or winding-up. Such notice shall be delivered at least ten
(10) business days prior to the date therein specified. 
 11. REPLACEMENT OF WARRANTS. On receipt of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such loss, theft, destruction or mutilation of this Warrant, on delivery of an indemnity agreement or security reasonably satisfactory
in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation of such Warrant, the Company at its expense will execute and deliver, in lieu thereof, a new Warrant of like tenor. 

12. NO IMPAIRMENT. Except to the extent as may be waived by the holder of this Warrant, the Company will not, by amendment of its charter
or through a Reorganization, Merger, dissolution, sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out
of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Purchaser against impairment. 
 13. SATURDAYS, SUNDAYS, HOLIDAYS, ETC. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall be a Saturday or Sunday or shall be a legal
U.S. holiday, then such action may be taken or such right may be exercised on the next succeeding day not a Saturday, Sunday or legal U.S. holiday. 
 14. TRANSFERS; EXCHANGES. (a) Subject to compliance with applicable federal and state securities laws and Section 9 hereof, this Warrant may be transferred by the Purchaser with respect to any
or all of the Warrant Stock purchasable hereunder. Upon surrender of this Warrant to the Company, together with the Notice of Assignment in the form attached hereto as Exhibit B duly completed and executed on behalf of the Purchaser, for
transfer of this Warrant as an entirety by Purchaser, the Company shall issue a new Warrant of the same denomination to the assignee. Upon surrender of this Warrant to the Company, together with the Notice of Assignment in the form attached hereto
as Exhibit B duly completed and executed on behalf of the Purchaser, for transfer of this Warrant with respect to a portion of the Warrant Stock purchasable hereunder, the Company shall issue a new Warrant to the assignee, in such
denomination as shall be requested by the Purchaser, and shall issue to the Purchaser a new Warrant covering the number of shares in respect of which this Warrant shall not have been transferred. 

(b) This Warrant is exchangeable, without expense, at the option of the Holder, upon presentation and surrender hereof to the Company for
other warrants of different denominations entitling the holder thereof to purchase in the aggregate the same number of shares of Common Stock purchasable hereunder. This Warrant may be divided or combined with other warrants that carry the same
rights upon presentation hereof at the principal office of the Company together with a written notice specifying the denominations in which new warrants are to be issued to the Holder and signed by the Holder hereof. The term “Warrants” as
used herein includes any warrants into which this Warrant may be divided or exchanged. 

  
 5 

 15. MISCELLANEOUS. (a) This Agreement shall be governed by and construed in accordance
with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof (other than Section 5-1401 of the General Obligations Law). Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by this Agreement (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, borough of Manhattan for the adjudication of any
dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such
suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. 

(b) All notices, requests, consents and other communications hereunder shall be in writing, shall be sent by confirmed facsimile or
electronic mail, or mailed by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, and shall be deemed given when so sent in the case of facsimile or electronic mail transmission, or when
so received in the case of mail or courier, and addressed as follows: (a) if to the Company, at 149 Commonwealth Drive, Menlo Park, California 94025, Attention: Chief Financial Officer; Facsimile: (650) 327-3270; E-Mail: crobb@corcept.com;
with a copy to Latham & Watkins LLP, 140 Scott Drive, Menlo Park, California 94025, Attention: Alan C. Mendelson; Facsimile: (650) 463-4693; E-Mail: alan.mendelson@lw.com and (b) if to the Purchaser, at such address or addresses
as may have been furnished by the Purchaser to the Company in writing. 
 (c) The invalidity or unenforceability of any
provision hereof shall in no way affect the validity or enforceability of any other provisions. 
 16. WAIVER. The Company will
not, by any voluntary action avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all provisions of this
Warrant and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment. 
 [Signature Page Follows] 

  
 6 

 IN WITNESS WHEREOF, this Warrant is issued effective as of the date first set forth above.

  

			
	CORCEPT THERAPEUTICS INCORPORATED
		
	By:	 	  

			
	Name:	 	G. Charles Robb
	Title:	 	Chief Financial Officer

 PURCHASER: 

 

			
	Accepted and Agreed:
		
	By:	 	  

	Name:
	Title:

 EXHIBIT A 

NOTICE OF INTENT TO EXERCISE 
 (To be signed only upon exercise of Warrant) 
 To: Corcept Therapeutics Incorporated 

The undersigned, the Purchaser of the attached Warrant, hereby irrevocably elects to exercise the purchase right represented by such
Warrant for, and to purchase thereunder,
                                        ( 
           ) shares of Common Stock of Corcept Therapeutics Incorporated and             herewith makes payment of
                                        Dollars
($        ) thereof. 
 The undersigned by its signature below it hereby represents
and warrants that it is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended, and agrees to be bound by the terms and conditions of the attached Warrant as of the date
hereof, including Section 9 thereof. 
  

			
	DATED:	 	 

  

			
	(Signature must conform in all respects to name of
the Purchaser as specified on the face of the
Warrant)
	
	  

	Name:	 	  

	Address:	 	  

	  

	  

 EXHIBIT B 

NOTICE OF ASSIGNMENT FORM 
 FOR VALUE RECEIVED,                     (the “Assignor”) hereby sells, assigns and
transfers all of the rights of the undersigned Assignor under the attached Warrant with respect to the number of shares of common stock of Corcept Therapeutics Incorporated (the “Company”) covered thereby set forth below, to the
following “Assignee” and, in connection with such transfer, represents and warrants to the Company that the transfer is in compliance with Section 9 of the Warrant and applicable federal and state securities laws: 

 

									
	NAME OF ASSIGNEE	 		 	ADDRESS/FAX NUMBER
					
	Dated:	 	  
	 		 	Signature:	 	  

					
		 		 		 	Witness:	 	  

 ASSIGNEE ACKNOWLEDGMENT 
 The undersigned Assignee acknowledges that it has reviewed the attached Warrant and by its signature below it hereby represents and warrants that it is an “accredited investor” as defined in
Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended, and agrees to be bound by the terms and conditions of the attached Warrant as of the date hereof, including Section 9 thereof. 

 

			
	Signature:	 	
 

			
		
	By:	 	  

	Its:	 	  

  

	
	Address:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]